Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Cancer Research

Background:

• Blood-based tests offer a non-invasive alternative to biopsies for disease diagnosis.
• Tumor-derived exosomes are promising biomarkers for cancer diagnosis and treatment monitoring.
• Current exosome isolation and analysis methods face technical challenges, limiting their clinical utility.

Purpose of the Study:

• To develop a microfluidic approach for rapid, sensitive, and comprehensive analysis of circulating exosomes.
• To enable selective isolation and molecular profiling of exosome subpopulations from minimal plasma volumes.
• To demonstrate the clinical utility of the platform for non-small-cell lung cancer biomarker assessment.

Main Methods:

• Development of an integrated microfluidic device combining immunoisolation and targeted protein analysis.
• Selective isolation of exosome subpopulations from 30 μL of plasma within approximately 100 minutes.
• Phenotyping of exosome subpopulations using common and tumor-specific markers.
• Multiparameter analysis of intravesicular biomarkers, including IGF-1R expression and phosphorylation.

Main Results:

• Achieved streamlined and expedited exosome analysis pipeline with improved detection sensitivity.
• Demonstrated selective subpopulation isolation and quantitative detection of surface and intravesicular biomarkers.
• Successfully assessed IGF-1R levels in plasma exosomes from non-small-cell lung cancer patients as a non-invasive alternative to biopsy.

Conclusions:

• The developed microfluidic platform significantly advances exosome analysis capabilities.
• This technology provides a critical infrastructure for improved understanding and clinical application of exosomes in cancer diagnostics.
• The platform holds potential for non-invasive cancer monitoring and personalized treatment strategies.